BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/2/2014 3:20:00 PM | Browse: 1054 | Download: 766
Publication Name World Journal of Gastroenterology
Manuscript ID 5758
Country South Korea
Received
2013-09-25 10:47
Peer-Review Started
2013-09-25 16:32
To Make the First Decision
2013-10-22 16:40
Return for Revision
2013-10-23 10:13
Revised
2013-11-15 15:40
Second Decision
2013-12-13 13:59
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-12-13 14:48
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-02-12 17:21
Publish the Manuscript Online
2014-02-26 11:18
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Targeted therapy in gastric cancer: Personalizing cancer treatment based on patient genome
Manuscript Source Invited Manuscript
All Author List Sun Min Lim, Jae Yun Lim and Jae Yong Cho
Funding Agency and Grant Number
Corresponding Author Dr. Jae Yong Cho, MD, PhD, Department of Medical Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, 712 Eonjuro, Gangnam-gu, Seoul 135-720, South Korea. chojy@yuhs.ac
Key Words Gastric cancer; Targeted therapy; Biomarker; Microarray; Sequencing
Core Tip Understanding the molecular mechanisms governing carcinogenesis, progression and prognosis of gastric cancer is a prerequisite for development of effective management strategies. Analysis of genomic and proteomic expression profiles of oncogenic signaling pathways have revealed different molecular subtypes of gastric cancer. Development of personalized cancer therapy regimens will specifically target aberrations that drive tumor growth and survival. Therefore, identifying and administering the appropriate drug based on genetic profiling will improve clinical outcomes and decrease toxicity. We anticipate that identification of novel cancer targets will further aid in understanding of cancer heterogeneity and in refinement of personalized therapeutic strategies.
Publish Date 2014-02-26 11:18
Citation Lim SM, Lim JY, Cho JY. Targeted therapy in gastric cancer: Personalizing cancer treatment based on patient genome. World J Gastroenterol 2014; 20(8): 2042-2050
URL http://www.wjgnet.com/1007-9327/full/v20/i8/2042.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i8.2042
Full Article (PDF) WJG-20-2042.pdf
Full Article (Word) WJG-20-2042.doc
Manuscript File 5758-Review.doc
Answering Reviewers 5758-Answering reviewers.pdf
Copyright License Agreement 5758-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 5758-Language certificate.pdf
Peer-review Report 5758-Peer reviews.pdf
Scientific Editor Work List 5758-Scientific editor work list.doc